Evidence map›Paper›PMID 37080678›Full record

ArticleCurrent topics in membranes2023

The role of hyaluronan in endothelial glycocalyx and potential preventative lifestyle strategy with advancing age.

Jisok Lim, Daniel Robert Machin, Anthony John Donato

Open access · greenAbstract read
In one paragraph

Article in Current topics in membranes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
17.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Endothelial Surface Glycocalyx in Vascular Functions and Diseases.Advances in experimental medicine and biology · 2026
    Review
  7. Western diet-induced endothelial glycocalyx remodeling is partially reversed by fasting.American journal of physiology. Heart and circulatory physiology · 2025
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jisok LimDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, United States.
Daniel Robert MachinDepartment of Nutrition & Integrative Physiology, Florida State University, Tallahassee, FL, United States.
Anthony John DonatoDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, United States; Geriatric Research, Education, and Clinical Center, Salt Lake City Veterans Affairs Medical Center, Salt Lake City, UT, United States; Department of Nutrition and Integrative Physiology, Salt Lake City, UT, United States; Department of Biochemistry, University of Utah, Salt Lake City, UT, United States; Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States. Electronic address: ifancher@udel.edu.
University of Utah · US

Funding

TRAINING IN CARDIOVASCULAR RESEARCHT32HL007576 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Stavros George Drakos, Robin M Shaw · 1985 to 2026
$10.6M
IMPACT OF T CELLS ON AGE-RELATED VASCULAR DYSFUNCTION: A TRANSLATIONAL APPROACH - DIVERSITY SUPPLEMENTR01AG060395 · NIA · UNIVERSITY OF UTAH · PI DONATO, ANTHONY JOHN · 2019 to 2023
$2.5M
Integrative Mechanisms of Vascular AgingR01AG077751 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anthony John Donato, Lisa A Lesniewski · 2023 to 2026
$1.8M
Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammationR01AG076748 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Lisa A Lesniewski · 2023 to 2026
$1.8M
Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and DysfunctionR44AG053131 · NIA · RECURSION PHARMACEUTICALS, LLC · PI DONATO, ANTHONY JOHN, GIBSON, CHRISTOPHER · 2016 to 2020
$1.6M
Telomere uncapping and arterial dysfunction: Novel mechanism and implications for agingR01AG050238 · NIA · UNIVERSITY OF UTAH · PI DONATO, ANTHONY JOHN · 2016 to 2020
$1.6M
The role of hyaluronan in age-related vascular and skeletal muscle dysfunctionR00AT010017 · NCCIH · FLORIDA STATE UNIVERSITY · PI MACHIN, DANIEL ROBERT · 2020 to 2022
$747k
NCCIH NIH HHS R00 AT010017NHLBI NIH HHS T32 HL007576NIA NIH HHS R01 AG050238NIA NIH HHS R01 AG060395NIA NIH HHS R01 AG076748NIA NIH HHS R01 AG077751NIA NIH HHS R44 AG053131
6 · The paper itself

Abstract

The endothelial glycocalyx (EG) is a gel-like structure that forms a layer in between the surface of the endothelium and lumen. EG was once thought to be merely a structural support for the endothelium. However, in recent years, the importance of EG as a first line of defense and a key regulator to endothelial integrity has been illuminated. With advanced age, EG deterioration becomes more noticeable and at least partially associated with endothelial dysfunction. Hyaluronan (HA), one of the critical components of the EG, has distinct properties and roles to the maintenance of EG and endothelial function. Therefore, given the intimate relationship between the EG and endothelium during the aging process, HA may serve as a promising therapeutic target to prevent endothelial dysfunction.

Indexed as

Hyaluronic AcidVascular DiseasesEndothelium, VascularGlycocalyxHumansHyaluronic AcidAerobic exerciseAgingCaloric restrictionDietary supplementationEndothelial-dependent dilationEndothelial functionEndothelial glycocalyxHigh molecular weight-hyaluronanHyaluronanHyaluronan synthaseLifestyle strategyLow molecular weight-hyaluronanNitric oxide

Identifiers

PMID37080678
PMCPMC10464581
OpenAlexW4323892775

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.